Aortic Aneurysm Market Trends

Growth Drivers

• Expanding pipeline and increasing investments: Government-led initiatives and public funding are conjugately fueling adoption in the market through spreading knowledge and providing financial support. For instance, in February 2025, NHS North West commenced a campaign for the abdominal aortic aneurysm (AAA) screening programme. This intended to educate and encourage eligible men to undergo a 10-minute, pain free scan. Similarly, in March 2024, LIOF and Chemelot Ventures collaboratively invested in TripleMed to help it achieve CE marking for AneuFix Endoleak Repair and AneuFill Prophylactic Sac Filling in treating AA. Additionally, the efforts to improve access to advanced care is empowering this sector for globalization.
• Evolving approach toward early detection: As the awareness about the importance of preventive measures spread worldwide, the success rates of treatments available in the market heightens. This impels consumer trust and inspire medical settings to adopt them, propelling the cash flow in this sector. Particularly, the integration of advanced technologies, such as AI and data-driven diagnosis, are ensuring progress in this field. On this note, in January 2023, Viz.ai introduced an AI-powered software, Viz Vascular Suite, to enable early detection and intervention for susceptible patients with vascular diseases, including AAA by automating the workflow. Such innovations are further inspiring other pioneers to invest in this sector.

Challenges 

• Lack of competency in pricing and market presence: Despite the comparative cost-effectiveness, the existing commodities in the market still remain unaffordable for a majority of the population from the underserved regions. The necessity of accommodating skilled surgeons, specialized devices, and advanced imaging cultivate higher overall expenses. However, developing affordable essentials tools is challenging while maintaining their quality and efficacy. Thus, the economic barrier continues to hinder worldwide adoption in this field. Moreover, sufficient reimbursement policies and extensive R&D is required to mitigate this financial disparity.